NEJM - Angiotensin Blockade in PKD

"Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease"

"CONCLUSIONS

Monotherapy with an ACE inhibitor was associated with blood-pressure control in most patients with ADPKD and stage 3 chronic kidney disease. The addition of an ARB did not alter the decline in the estimated GFR. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; HALT-PKD [Study B] ClinicalTrials.gov number, NCT01885559.)"

http://www.nejm.org/doi/full/10.1056/NEJMoa1402686